MNKD MannKind Corporation
Stock Price & Overview

$4.45-0.05 (-1.11%)4:00 PM 05/15/24
NASDAQ | $USD | Pre-Market: $4.50 +0.05 (+1.12%) 8:36 AM

Charts

EPS
PE
Div Rate
Yield
Market Cap
Volume
Prev. Close

Quant Ranking

Ratings Summary

People Also Follow

Similar to MNKD

ETFs Holding MNKD

MNKD Company Profile

MannKind Corporation logo
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company’s product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
Employees
413
Founded
1991
Address
  • 1 Casper Street
  • Danbury, CT, 06810
  • United States
Phone Number
818 661 5000

MNKD Revenue

MNKD Earnings Per Share

Earnings Estimates

Earnings Revisions

Valuation

Growth

Profitability

Momentum

Capital Structure

Dividends

MNKD Ownership

MNKD Peers

Risk

Technicals

MNKD Transcripts

Investor Presentations

MNKD SEC Filings

MNKD Income Statement

MNKD Balance Sheet

MNKD Cash Flow Statement

MNKD Long Term Solvency

Discover More

You may be interested in:

MannKind Corporation (MNKD) Frequently Asked Questions

People Also Follow

Similar to MNKD

ETFs Holding MNKD